CDH1 and lip and oral cavity carcinoma: When we treated 3D-cultured oral cancer cell spheroids with cetuximab, the SAS spheroids showed no difference in morphology and no change in E-cadherin among the cetuximab concentrations, whereas the HSC-3 spheroids showed a concentration-dependent disintegration of spheroids and attenuation of E-cadherin (Fig. 4).